APPETITE SUPPRESSANT COMPOSITION

• US 20100098783A1
• Filed: 10/16/2008
• Published: 04/22/2010
• Est. Priority Date: 10/16/2008
• Status: Active Grant

• Current Assignee: PruvIt Ventures Inc.
• Original Assignee: ViSalus Holdings LLC (Luminex Home Décor & Fragrance Holding Corp.)
• Inventors: Sommerfeld, Audrey, Witherly, Steve
• Granted Patent: US 8,455,024 B2
• Time in Patent Office: Days
• US Class Current: 424/725
• CPC Class Codes: A61K 2300/00 Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
• CPC Class Codes: A61K 31/405 Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
• CPC Class Codes: A61K 36/27 Asclepiadaceae (Milkweed family), e.g. hoya

Abstract

A chewable appetite suppressant composition includes a Hoodia extract, a 5-hydroxytryptophan, a Gymnema Slyvestris, and at least one amino acid derivative. The chewable appetite suppressant composition may further include flavorants.

Claims

1. A chewable appetite suppressant composition comprising:

a Hoodia extract in an amount from about 10 to about 250 mg/total mg;

a 5-hydroxytryptophan in an amount from about 10 to about 250 mg/total mg;

a Gymnema Slyvestris extract in an amount from about 10 to about 250 mg/total mg; and

at least one amino acid derivative.

2. The chewable appetite suppressant composition of claim 1, wherein the at least one amino acid derivative is a gamma-aminobutyric acid present in an amount from about 10 to about 250 mg/total mg.

3. The chewable appetite suppressant composition of claim 2, further comprising a bitter blocker.

4. The chewable appetite suppressant composition of claim 1, wherein the Hoodia extract is present in an amount of from about 100 to about 150 mg/total mg.

5. The chewable appetite suppressant composition of claim 1, wherein the 5-hydroxytryptophan is present in an amount of from about 40 to about 60 mg/total mg.

6. The chewable appetite suppressant composition of claim 1, wherein the Gymnema Slyvestris extract is present in an amount of from about 40 to about 60 mg/total mg.

7. The chewable appetite suppressant composition of claim 1, further comprising at least one flavorant.

8. The chewable appetite suppressant composition of claim 1, further comprising a DL-phenylalanine.

9. The chewable appetite suppressant composition of claim 1, wherein the chewable appetite suppressant composition is delivered in a tablet form.

10. A chewable appetite suppressant composition comprising:

a Hoodia extract in an amount from about 10 to about 250 mg/total mg;

a DL-phenylalanine in an amount from about 10 to about 500 mg/total mg;

a gamma-aminobutyric acid in an amount from about 10 to about 250 mg/total mg;

a 5-hydroxytryptophan in an amount from about 10 to about 250 mg/total mg; and

a Gymnema Slyvestris extract in an amount from about 10 to about 250 mg/total mg.

11. The chewable appetite suppressant composition of claim 10, wherein the 5-hydroxytryptophan is present in an amount of from about 40 to about 60 mg/total mg.

12. The chewable appetite suppressant composition of claim 10, wherein the Gymnema Slyvestris extract is present in an amount of from about 40 to about 60 mg/total mg.

13. The chewable appetite suppressant composition of claim 10, wherein the DL-phenylalanine is present in an amount of from about 80 to about 120 mg/total mg.

14. The chewable appetite suppressant composition of claim 10, wherein the Hoodia extract is present in an amount of from about 100 to about 150 mg/total mg.

15. The chewable appetite suppressant composition of claim 10, further comprising a bitter blocker.

16. A chewable appetite suppressant tablet comprising:

a Hoodia extract in an amount from about 10 to about 250 mg;

a 5-hydroxytryptophan in an amount from about 10 to about 250 mg;

a Gymnema Slyvestris extract in an amount from about 10 to about 250 mg; and

at least one amino acid derivative.

17. The chewable appetite suppressant tablet of claim 16, wherein the at least one amino acid derivative is a gamma-aminobutyric acid present in an amount from about 10 to about 250 mg.

18. The chewable appetite suppressant tablet of claim 16, wherein the Hoodia extract is present in an amount of from about 100 to about 150 mg.

19. The chewable appetite suppressant tablet of claim 16, wherein the 5-hydroxytryptophan is present in an amount of from about 40 to about 60 mg.

20. The chewable appetite suppressant tablet of claim 16, wherein the 5-hydroxytryptophan is present in an amount of from about 40 to about 60 mg.